TY - JOUR
T1 - Chlamydial infection in women along the US-Mexico border
AU - Baldwin, S. B.
AU - Djambazov, B.
AU - Papenfuss, M.
AU - Abrahamsen, M.
AU - Denman, C.
AU - Guernsey De Zapien, J.
AU - Ortega, L.
AU - Navarro Henze, J. L.
AU - Hunter, J.
AU - Rojas, M.
AU - Garcia, F.
AU - Giuliano, A. R.
N1 - Funding Information:
Baldwin S B Veterans Health Administration of Greater Los Angeles, Sepulveda Ambulatory Care Center, 16111 Plummer St, Sepulveda, CA and H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Djambazov B Arizona Department of Health Services, Phoenix, AZ, USA Papenfuss M H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Abrahamsen M H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Denman C El Colegio de Sonora, Hermosillo, Sonora, Mexico Guernsey de Zapien J Rural Health Office, and Arizona College of Public Health, University of Arizona, Tucson, AZ, USA Ortega L Pan American Health Organization, El Paso, TX, USA Navarro Henze J L Secretaria de Salud Publica de Sonora, Hermosillo, Sonora, Mexico Hunter J Arizona Cancer Center, Tucson, AZ, USA Rojas M Pima County Health Department, Tucson, AZ, USA García F Veterans Health Administration of Greater Los Angeles, Sepulveda Ambulatory Care Center, 16111 Plummer St, Sepulveda, CA, USA Giuliano A R H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 01 12 2004 15 12 815 821 © 2004 Royal Society of Medicine Press 2004 Few studies have reported on sexually transmitted infections at the US–Mexico border, so the prevalence of Chlamydia trachomatis in this population remains uncertain. This binational project investigated the prevalence of, and risk factors for, C. trachomatis among women along the Arizona, US–Sonora, Mexico border. Women who self-referred for routine gynaecological care were invited to complete an interviewer-administered questionnaire and to undergo a Pap smear, C. trachomatis test, and HPV test. In 2270 women, C. trachomatis prevalence overall was 8.2% as measured by hybrid capture and 2.6% by enzyme immunoassay. Infection was associated with young age, a history of new sexual partner(s) in the previous three months, HPV infection, and proximity of clinic to the international border. Antibiotic use in the previous 30 days was associated with decreased odds of infection. Women in Arizona–Sonora border communities are at increased risk for C. trachomatis infection compared to women attending clinics in non-border locations. CHLAMYDIA SEXUALLY TRANSMITTED DISEASES BORDER HEALTH INTERNATIONAL HEALTH
PY - 2004/12
Y1 - 2004/12
N2 - Few studies have reported on sexually transmitted infections at the US-Mexico border, so the prevalence of Chlamydia trachomatis in this population remains uncertain. This binational project investigated the prevalence of, and risk factors for, C. trachomatis among women along the Arizona, US-Sonora, Mexico border. Women who self-referred for routine gynaecological care were invited to complete an interviewer-administered questionnaire and to undergo a Pap smear, C. trachomatis test, and HPV test. In 2270 women, C. trachomatis prevalence overall was 8.2% as measured by hybrid capture and 2.6% by enzyme immunoassay. Infection was associated with young age, a history of new sexual partner(s) in the previous three months, HPV infection, and proximity of clinic to the international border. Antibiotic use in the previous 30 days was associated with decreased odds of infection. Women in Arizona-Sonora border communities are at increased risk for C. trachomatis infection compared to women attending clinics in non-border locations.
AB - Few studies have reported on sexually transmitted infections at the US-Mexico border, so the prevalence of Chlamydia trachomatis in this population remains uncertain. This binational project investigated the prevalence of, and risk factors for, C. trachomatis among women along the Arizona, US-Sonora, Mexico border. Women who self-referred for routine gynaecological care were invited to complete an interviewer-administered questionnaire and to undergo a Pap smear, C. trachomatis test, and HPV test. In 2270 women, C. trachomatis prevalence overall was 8.2% as measured by hybrid capture and 2.6% by enzyme immunoassay. Infection was associated with young age, a history of new sexual partner(s) in the previous three months, HPV infection, and proximity of clinic to the international border. Antibiotic use in the previous 30 days was associated with decreased odds of infection. Women in Arizona-Sonora border communities are at increased risk for C. trachomatis infection compared to women attending clinics in non-border locations.
KW - Border health
KW - Chlamydia
KW - International health
KW - Sexually transmitted diseases
UR - http://www.scopus.com/inward/record.url?scp=19944388238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944388238&partnerID=8YFLogxK
U2 - 10.1258/0956462042563792
DO - 10.1258/0956462042563792
M3 - Article
C2 - 15601488
AN - SCOPUS:19944388238
VL - 15
SP - 815
EP - 821
JO - International Journal of STD and AIDS
JF - International Journal of STD and AIDS
SN - 0956-4624
IS - 12
ER -